Literature DB >> 16373172

Post-translational amino acid racemization in the frog skin peptide deltorphin I in the secretion granules of cutaneous serous glands.

Constance Auvynet1, Nabila Seddiki, Irene Dunia, Pierre Nicolas, Mohamed Amiche, Claire Lacombe.   

Abstract

The dermal glands of the South American hylid frog Phyllomedusa bicolor synthesize and expel huge amounts of cationic, alpha-helical, 24- to 33-residue antimicrobial peptides, the dermaseptins B. These glands also produce a wide array of peptides that are similar to mammalian hormones and neuropeptides, including a heptapeptide opioid containing a D-amino acid, deltorphin I (Tyr-DAla-Phe-Asp-Val-Val-Gly NH2). Its biological activity is due to the racemization of L-Ala2 to D-Ala. The dermaseptins B and deltorphins are all derived from a single family of precursor polypeptides that have an N-terminal preprosequence that is remarkably well conserved, although the progenitor sequences giving rise to mature opioid or antimicrobial peptides are markedly different. Monoclonal and polyclonal antibodies were used to examine the cellular and ultrastructural distributions of deltorphin I and dermaseptin B in the serous glands by immunofluoresence confocal microscopy and immunogold-electron microscopy. Preprodeltorphin I and preprodermaseptins B are sorted into the regulated pathway of secretion, where they are processed to give the mature products. Deltorphin I, [l-Ala2]-deltorphin I and dermaseptin B are all stored together in secretion granules which accumulate in the cytoplasm of all serous glands. We conclude that the L- to D-amino acid isomerization of the deltorphin I occurs in the secretory granules as a post-translational event. Thus the specificity of isomerization depends on the presence of structural and/or conformational determinants in the peptide N-terminus surrounding the isomerization site.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373172     DOI: 10.1016/j.ejcb.2005.09.022

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  7 in total

Review 1.  Emerging knowledge of regulatory roles of D-amino acids in bacteria.

Authors:  Felipe Cava; Hubert Lam; Miguel A de Pedro; Matthew K Waldor
Journal:  Cell Mol Life Sci       Date:  2010-12-14       Impact factor: 9.261

2.  Tight binding of transition-state analogues to a peptidyl-aminoacyl-L/D-isomerase from frog skin.

Authors:  Verena Gehmayr; Christa Mollay; Lorenz Reith; Norbert Müller; Alexander Jilek
Journal:  Chembiochem       Date:  2011-07-07       Impact factor: 3.164

3.  Studies of the antitumor mechanism of action of dermaseptin B2, a multifunctional cationic antimicrobial peptide, reveal a partial implication of cell surface glycosaminoglycans.

Authors:  Célia Dos Santos; Sabah Hamadat; Karen Le Saux; Clara Newton; Meriem Mazouni; Loussiné Zargarian; Mickael Miro-Padovani; Patricia Zadigue; Jean Delbé; Yamina Hamma-Kourbali; Mohamed Amiche
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

4.  Racemization in Post-Translational Modifications Relevance to Protein Aging, Aggregation and Neurodegeneration: Tip of the Iceberg.

Authors:  Victor V Dyakin; Thomas M Wisniewski; Abel Lajtha
Journal:  Symmetry (Basel)       Date:  2021-03-11       Impact factor: 2.713

Review 5.  Advancing d-amino acid-containing peptide discovery in the metazoan.

Authors:  David H Mast; James W Checco; Jonathan V Sweedler
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-09-28       Impact factor: 3.036

6.  Conformational and functional effects induced by D- and L-amino acid epimerization on a single gene encoded peptide from the skin secretion of Hypsiboas punctatus.

Authors:  Mariana T Q de Magalhães; Eder A Barbosa; Maura V Prates; Rodrigo M Verly; Victor Hugo O Munhoz; Ivan E de Araújo; Carlos Bloch
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

7.  Discovery of two skin-derived dermaseptins and design of a TAT-fusion analogue with broad-spectrum antimicrobial activity and low cytotoxicity on healthy cells.

Authors:  Haohao Zhu; Xiyan Ding; Wei Li; Tulin Lu; Chengbang Ma; Xinping Xi; Lei Wang; Mei Zhou; Roberta Burden; Tianbao Chen
Journal:  PeerJ       Date:  2018-09-19       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.